Bruch HP - Search Results

1

VEGF isoforms and mutations in human colorectal cancer.

Uthoff SM, Duchrow M, Schmidt MHH, Broll R, Bruch HP, Strik MW, Galandiuk S. Uthoff SM, et al. Among authors: bruch hp. Int J Cancer. 2002 Sep 1;101(1):32-6. doi: 10.1002/ijc.10552. Int J Cancer. 2002. PMID: 12209585

2

Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas.

Broll R, Stark A, Windhövel U, Best R, Strik MW, Schimmelpenning H, Schwandner O, Kujath P, Bruch HP, Duchrow M. Broll R, et al. Among authors: bruch hp. Eur J Cancer. 1999 Jul;35(7):1083-8. doi: 10.1016/s0959-8049(99)00058-1. Eur J Cancer. 1999. PMID: 10533452

3

Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?

Broll R, Erdmann H, Duchrow M, Oevermann E, Schwandner O, Markert U, Bruch HP, Windhövel U. Broll R, et al. Among authors: bruch hp. Eur J Surg Oncol. 2001 Feb;27(1):37-42. doi: 10.1053/ejso.2000.1052. Eur J Surg Oncol. 2001. PMID: 11237490

4

Assessment of proliferative activity in colorectal carcinomas by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).

Duchrow M, Häsemeyer S, Broll R, Bruch HP, Windhövel U. Duchrow M, et al. Among authors: bruch hp. Cancer Invest. 2001;19(6):588-96. doi: 10.1081/cnv-100104286. Cancer Invest. 2001. PMID: 11486701

5

Proliferation marker pKi-67 affects the cell cycle in a self-regulated manner.

Schmidt MH, Broll R, Bruch HP, Duchrow M. Schmidt MH, et al. Among authors: bruch hp. J Cell Biochem. 2002;87(3):334-41. doi: 10.1002/jcb.10302. J Cell Biochem. 2002. PMID: 12397615

6

Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay.

Schiedeck TH, Wellm C, Roblick UJ, Broll R, Bruch HP. Schiedeck TH, et al. Among authors: bruch hp. Dis Colon Rectum. 2003 Jun;46(6):818-25. doi: 10.1007/s10350-004-6662-6. Dis Colon Rectum. 2003. PMID: 12794585

7

Proliferation marker pKi-67 occurs in different isoforms with various cellular effects.

Schmidt MH, Broll R, Bruch HP, Finniss S, Bögler O, Duchrow M. Schmidt MH, et al. Among authors: bruch hp. J Cell Biochem. 2004 Apr 15;91(6):1280-92. doi: 10.1002/jcb.20016. J Cell Biochem. 2004. PMID: 15048881

8

High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.

Ihmann T, Liu J, Schwabe W, Häusler P, Behnke D, Bruch HP, Broll R, Windhövel U, Duchrow M. Ihmann T, et al. Among authors: bruch hp. J Cancer Res Clin Oncol. 2004 Dec;130(12):749-56. doi: 10.1007/s00432-004-0612-5. Epub 2004 Sep 21. J Cancer Res Clin Oncol. 2004. PMID: 15449182

9

Effect of cyclooxygenase-2 antisense oligodeoxyribonucleotides in A-549 lung cancer cells.

Windhövel U, Haasper C, Duchrow M, Bruch HP, Broll R. Windhövel U, et al. Among authors: bruch hp. Anticancer Res. 2004 Nov-Dec;24(6):3789-94. Anticancer Res. 2004. PMID: 15736413 Free article.

10

[Demonstration of the angiogenic cytokine vascular endothelial growth factor (VEGF) by non radioactive in situ hybridization].

Strik MW, Laus C, Duchrow M, Broll R, Bruch HP. Strik MW, et al. Among authors: bruch hp. Ann Anat. 1997 Dec;179(6):559-62. Ann Anat. 1997. PMID: 9480624 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters